🧬 PT‑141 (Bremelanotide) Peptide — 10 mg

High‑Purity Melanocortin‑Receptor Research Peptide for CNS, Neuroendocrine & Receptor‑Pathway Studies (Canada)

PT‑141 (Bremelanotide) is a high‑purity, research‑grade melanocortin‑receptor peptide analog widely used in laboratory research involving central nervous system (CNS) signaling, melanocortin‑pathway activation, neuroendocrine regulation, and peptide–receptor interaction dynamics.

Supplied by BlueNexLabs, PT‑141 is provided as a lyophilized peptide (10 mg) with COA‑verified purity, analytical consistency, and audit‑safe Research‑Use‑Only (RUO) labeling, supporting advanced experimental workflows in Canadian research environments.

🔬 Overview of PT‑141 in Research Settings

PT‑141 is a synthetic peptide derived from the α‑MSH (alpha‑melanocyte‑stimulating hormone) sequence, designed to support controlled investigation of melanocortin receptor signaling, particularly within central regulatory pathways.

In research contexts, PT‑141 is frequently referenced in studies examining:

• Melanocortin‑receptor signaling (MC3R / MC4R)

• CNS‑linked neuroendocrine pathways

• Hypothalamic signaling and regulatory networks

• Peptide–receptor binding and activation kinetics

• Structure–function relationships of melanocortin analogs

Its receptor specificity and predictable in‑vitro behavior make PT‑141 a valuable model peptide for CNS‑focused and receptor‑pathway research.

🧪 What Is PT‑141?

PT‑141 (Bremelanotide) is a synthetic melanocortin‑receptor agonist developed from α‑MSH‑based peptide analogs and used in laboratory research involving central melanocortin signaling systems.

In controlled research environments, PT‑141 is used to study:

• MC3R and MC4R receptor‑pathway activity

• Central melanocortin signaling within the CNS

• Hypothalamic neuroendocrine signaling models

• Peptide–receptor binding affinity and activation profiles

• Neurochemical modulation and central regulatory circuits

Unlike peripherally focused peptides, PT‑141 is primarily referenced for its central receptor‑pathway relevance, supporting CNS‑linked experimental models.

📡 Mechanistic Research Overview (Audit‑Safe)

🧬 Melanocortin‑Receptor Activation (MC3R / MC4R)

• Referenced in studies examining melanocortin‑linked transcriptional activity

• Used in CNS‑mediated receptor‑signaling models

• Supports investigation of neuroendocrine‑associated signaling pathways

🧠 Hypothalamic & CNS‑Signaling Pathways

• Applied in research involving central regulatory circuits

• Supports neurochemical‑modulation studies

• Used in multi‑pathway CNS signaling evaluations

🔗 Peptide–Receptor Interaction Dynamics

• Examined in binding‑affinity and activation assays

• Used in comparative analysis versus α‑MSH and related analogs

• Supports peptide‑mediated CNS‑pathway modeling

🧱 Molecular & Chemical Characteristics

Type: Synthetic melanocortin‑receptor peptide
Form: Lyophilized powder
Fill Size: 10 mg
Origin: Derived from α‑MSH peptide sequence
Identity Verification: Mass Spectrometry (MS)
Purity Analysis: HPLC / UPLC

Structural & Biochemical Notes

• Demonstrates predictable receptor‑binding behavior in vitro

• Stable in lyophilized form under proper storage conditions

• Sensitive to hydrolysis and oxidation after reconstitution

🔬 Research Focus Areas

PT‑141 is commonly referenced in laboratory research involving:

• Melanocortin‑receptor activation and CNS‑signaling models

• Hypothalamic neuroendocrine pathway studies

• Peptide–receptor binding and activation assays

• Neurochemical modulation and central regulatory circuits

• Structure–function analysis of melanocortin‑analog peptides

• Multi‑pathway CNS‑linked transcriptional investigations

Its clean mechanistic profile supports controlled, pathway‑specific research workflows in regulated laboratory settings.

❄️ Storage & Handling Guidelines

• Store lyophilized peptide at –20 °C, protected from light and moisture

• Reconstituted solutions: 2–8 °C, short‑term research use only

• Avoid repeated freeze–thaw cycles; aliquot if necessary

• Avoid prolonged exposure to room temperature after reconstitution

• Use sterile preparation techniques and low‑binding labware

📄 Certificate of Analysis & Documentation

Each batch of PT‑141 supplied by BlueNexLabs includes audit‑ready, batch‑specific documentation, ensuring transparency and reproducibility:

• Mass Spectrometry identity confirmation

• HPLC / UPLC purity profile

• Solvent system disclosure

• Lot and batch traceability

• Research‑Use‑Only (RUO) designation

🔗 View Certificate of Analysis (COA)
🔗 Learn About Our Testing Standards
🔗 Explore the BlueNexLabs Research Peptide Catalog

🇨🇦 Supplied for Canadian Research Laboratories

BlueNexLabs supplies PT‑141 research peptide to laboratories across Vancouver, Toronto, Montreal, Calgary, Edmonton, Ottawa, and throughout Canada.

Why Researchers Choose BlueNexLabs

• 🇨🇦 Canada‑wide domestic shipping

• 📄 COA‑verified, traceable batches

• 🧪 Audit‑safe RUO labeling

• ⚡ Fast fulfillment & responsive support

• 🔬 Research‑focused CNS & receptor‑pathway peptide catalog

⚠️ Compliance Notice

This product is supplied strictly for laboratory research use only (RUO).
Not for human or veterinary use.
No medical, therapeutic, metabolic, diagnostic, or performance‑related claims are made or implied.